Company news
MicroPort Scientific Corp. news in 2026
MicroPort Scientific Corp.'s news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 4, 2026
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
October 29, 2026
Unaudited financial information of shanghai MicroPort endovascular medtech (group) co., ltd. for the nine months ended 30 September 2026
October 29, 2026
List of directors and their roles and functions
October 25, 2026
Resignation of director; and appointment of executive director, chief executive officer and authorised representative
October 25, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 7, 2026
MicroPort Scientific: Artemis Dream® Intracranial Sirolimus-Eluting Stent System Enters NMPA Innovative Medical Device Special Review Program
September 8, 2026
MicroPort Scientific: ® Coronary Announces FireShield™ Coronary Covered Stent System Enters NMPA Special Review Procedure for Innovative Medical Devices
September 2, 2026
MicroPort Scientific: ® CardioFlow Announces Leadership Transition
August 28, 2026
® Endovastec™’s Aorfix™ Endograft System Granted NMPA Green Channel Designation for Innovative Medical Devices
August 27, 2026
® Enters into Letter of Intent with Tinavi for Potential Disposal of International Orthopedics Business
July 24, 2026
CardioFlow Enrolls First Patients Worldwide in STARLIGHT Clinical Trial Evaluating the LINEA™ Pacing Lead for LBBAP
June 29, 2026
® Appoints Greg Holman as Chief Commercial Officer
May 27, 2026
APOLLO Dream® Sirolimus Target Eluting Stent System Granted FDA Breakthrough Device Designation
March 30, 2026
FDA Grants Breakthrough Device Designation to Endovastec™’s Hector™ Multi-Branch Thoracic Stent Graft System
March 13, 2026
Toumai® Laparoscopic Surgical Robot Surpasses 200 Global Commercial Orders
March 2, 2026
MicroPort Scientific: CardioFlow Announces Commercial Launch of FLEXIGO™ 3D delivery system for LBBAP in Europe and Australia
February 10, 2026